{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:54:58Z","timestamp":1790776498141,"version":"4.1.0"},"reference-count":63,"publisher":"e-Century Publishing Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/jtnq4812","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T23:16:03Z","timestamp":1712272563000},"page":"1071-1086","source":"Crossref","is-referenced-by-count":5,"title":["Tolypothrix Dichloromethane Ethylacetate fraction (TDEF) inhibits cisplatin resistance H357 cell through PI3K\/AKT\/beta-catenin pathway"],"prefix":"10.62347","volume":"14","author":[{"given":"Rameshwari","family":"Heisnam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1245\/s10434-022-12151-6","article-title":"GLOBOCAN 2020 report on global cancer burden: challenges and opportunities for surgical oncologists","volume":"29","author":"SVS","year":"2022","unstructured":"Deo SVS, Sharma J and Kumar S. GLOBOCAN 2020 report on global cancer burden: challenges and opportunities for surgical oncologists. Ann Surg Oncol 2022; 29: 6497-6500.","journal-title":"Ann Surg Oncol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12957-018-1308-7","article-title":"Effect of neoadjuvant chemotherapy and its correlation with HPV status, EGFR, Her-2-neu, and GADD45 expression in oral squamous cell carcinoma","volume":"16","author":"Pandey","year":"2018","unstructured":"Pandey M, Kannepali KK, Dixit R and Kumar M. Effect of neoadjuvant chemotherapy and its correlation with HPV status, EGFR, Her-2-neu, and GADD45 expression in oral squamous cell carcinoma. World J Surg Oncol 2018; 16: 20.","journal-title":"World J Surg Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","unstructured":"Mansoori B, Mohammadi A, Davudian S, Shirjang S and Baradaran B. The different mechanisms of cancer drug resistance: a brief review. Adv Pharm Bull 2017; 7: 339-348.","journal-title":"Adv Pharm Bull"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10585-018-9903-0","article-title":"The challenge of drug resistance in cancer treatment: a current overview","volume":"35","author":"Nikolaou","year":"2018","unstructured":"Nikolaou M, Pavlopoulou A, Georgakilas AG and Kyrodimos E. The challenge of drug resistance in cancer treatment: a current overview. Clin Exp Metastasis 2018; 35: 309-318.","journal-title":"Clin Exp Metastasis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors of cancer stem cells by high-throughput screening","volume":"138","author":"Gupta","year":"2009","unstructured":"Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA and Lander ES. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009; 138: 645-659.","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10811-010-9506-x","article-title":"Filamentous tropical marine cyanobacteria: a rich source of natural products for anticancer drug discovery","volume":"22","author":"Tan","year":"2010","unstructured":"Tan LT. Filamentous tropical marine cyanobacteria: a rich source of natural products for anticancer drug discovery. J Appl Phycol 2010; 22: 659-676.","journal-title":"J Appl Phycol"},{"key":"ref6","unstructured":"Ahmed W, El-Semary N, Abd El-Hameed O, El Tawill G and Ibrahim D. Bioactivity and cytotoxic effect of cyanobacterial toxin against hepatocellular carcinoma. J Cancer Sci Ther 2017; 9: 505-511."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.phytochem.2007.01.012","article-title":"Bioactive natural products from marine cyanobacteria for drug discovery","volume":"68","author":"Tan","year":"2007","unstructured":"Tan LT. Bioactive natural products from marine cyanobacteria for drug discovery. Phytochemistry 2007; 68: 954-979.","journal-title":"Phytochemistry"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/md6010001","article-title":"Antimicrobial and cytotoxic assessment of marine cyanobacteria - Synechocystis and Synechococcus","volume":"6","author":"RF","year":"2008","unstructured":"Martins RF, Ramos MF, Herfindal L, Sousa JA, Sk&#xE6;rven K and Vasconcelos VM. Antimicrobial and cytotoxic assessment of marine cyanobacteria - Synechocystis and Synechococcus. Mar Drugs 2008; 6: 1-11.","journal-title":"Mar Drugs"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2174\/1871520615666151026094028","article-title":"A review on novel breast cancer therapies: photodynamic therapy and plant derived agent induced cell death mechanisms","volume":"16","author":"George","year":"2016","unstructured":"George BP and Abrahamse H. A review on novel breast cancer therapies: photodynamic therapy and plant derived agent induced cell death mechanisms. Anticancer Agents Med Chem 2016; 16: 793-801.","journal-title":"Anticancer Agents Med Chem"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.drudis.2013.05.010","article-title":"Pharmaceutical agents from filamentous marine cyanobacteria","volume":"18","author":"Tan","year":"2013","unstructured":"Tan LT. Pharmaceutical agents from filamentous marine cyanobacteria. Drug Discov Today 2013; 18: 863-871.","journal-title":"Drug Discov Today"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1099\/ijs.0.027581-0","article-title":"Phenotypic variability and phylogenetic relationships of the genera Tolypothrix and Calothrix (Nostocales, Cyanobacteria) from running water","volume":"61","author":"Berrendero","year":"2011","unstructured":"Berrendero E, Perona E and Mateo P. Phenotypic variability and phylogenetic relationships of the genera Tolypothrix and Calothrix (Nostocales, Cyanobacteria) from running water. Int J Syst Evol Microbiol 2011; 61: 3039-3051.","journal-title":"Int J Syst Evol Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-61779-108-6_8","article-title":"Annexin V\/7-AAD staining in keratinocytes","volume":"740","author":"Zimmermann","year":"2011","unstructured":"Zimmermann M and Meyer N. Annexin V\/7-AAD staining in keratinocytes. Methods Mol Biol 2011; 740: 57-63.","journal-title":"Methods Mol Biol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2001-1326-2-3","article-title":"Mechanisms of chemoresistance in cancer stem cells","volume":"2","author":"Abdullah","year":"2013","unstructured":"Abdullah LN and Chow EK. Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med 2013; 2: 3.","journal-title":"Clin Transl Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/mc.21863","article-title":"Metabolic symbiosis in cancer: refocusing the Warburg lens","volume":"52","author":"Nakajima","year":"2013","unstructured":"Nakajima EC and Van Houten B. Metabolic symbiosis in cancer: refocusing the Warburg lens. Mol Carcinog 2013; 52: 329-337.","journal-title":"Mol Carcinog"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0092-8674(00)81732-8","article-title":"Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development","volume":"94","author":"Cecconi","year":"1998","unstructured":"Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA and Gruss P. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 1998; 94: 727-737.","journal-title":"Cell"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S1074-7613(00)80609-3","article-title":"Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas\/Apo1, and DR3 and is lethal prenatally","volume":"9","author":"Varfolomeev","year":"1998","unstructured":"Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, Lapidot T, Soffer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonai P and Wallach D. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas\/Apo1, and DR3 and is lethal prenatally. Immunity 1998; 9: 267-276.","journal-title":"Immunity"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","article-title":"The many roles of FAS receptor signaling in the immune system","volume":"30","author":"Strasser","year":"2009","unstructured":"Strasser A, Jost PJ and Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity 2009; 30: 180-192.","journal-title":"Immunity"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ctrv.2013.08.006","article-title":"Strategies for co-targeting the PI3K\/AKT\/mTOR pathway in NSCLC","volume":"40","author":"Heavey","year":"2014","unstructured":"Heavey S, O&#x2019;Byrne KJ and Gately K. Strategies for co-targeting the PI3K\/AKT\/mTOR pathway in NSCLC. Cancer Treat Rev 2014; 40: 445-456.","journal-title":"Cancer Treat Rev"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Liu Y, Yang H, Chen T, Luo Y, Xu Z, Li Y and Yang J. Silencing of receptor tyrosine kinase ROR1 inhibits tumor-cell proliferation via PI3K\/AKT\/mTOR signaling pathway in lung adenocarcinoma. PLoS One 2015; 10: e0127092.","DOI":"10.1371\/journal.pone.0127092"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"MacDonald BT and He X. Frizzled and LRP5\/6 receptors for Wnt\/&#x3B2;-catenin signaling. Cold Spring Harb Perspect Biol 2012; 4: a007880.","DOI":"10.1101\/cshperspect.a007880"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1038\/sj.onc.1210053","article-title":"Wnts as ligands: processing, secretion and reception","volume":"25","author":"Mikels","year":"2006","unstructured":"Mikels AJ and Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene 2006; 25: 7461-7468.","journal-title":"Oncogene"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Willert K and Nusse R. Wnt proteins. Cold Spring Harb Perspect Biol 2012; 4: a007864.","DOI":"10.1101\/cshperspect.a007864"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1039\/C5NP00074B","article-title":"Natural compounds with Wnt signal modulating activity","volume":"32","author":"RG","year":"2015","unstructured":"Fuentes RG, Arai MA and Ishibashi M. Natural compounds with Wnt signal modulating activity. Nat Prod Rep 2015; 32: 1622-1628.","journal-title":"Nat Prod Rep"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1023\/A:1008170007044","article-title":"Allelopathic actions of the alkaloid 12-epi-hapalindole E isonitrile and calothrixin A from cyanobacteria of the genera Fischerella and Calothrix","volume":"12","author":"Thanh Doan","year":"2000","unstructured":"Thanh Doan N, Rickards RW, Rothschild JM and Smith GD. Allelopathic actions of the alkaloid 12-epi-hapalindole E isonitrile and calothrixin A from cyanobacteria of the genera Fischerella and Calothrix. J Appl Phycol 2000; 12: 409-416.","journal-title":"J Appl Phycol"},{"key":"ref25","unstructured":"Hossain MA, Islam A, Jolly Y and Kabir M. A new fl avonol glycoside from the seeds of Zea Mays. Indian J Chem 2006; 45: 1319-1321."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.","journal-title":"J Immunol Methods"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10495-020-01591-8","article-title":"DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG","volume":"25","author":"Shriwas","year":"2020","unstructured":"Shriwas O, Priyadarshini M, Samal SK, Rath R, Panda S, Das Majumdar SK, Muduly DK, Botlagunta M and Dash R. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG. Apoptosis 2020; 25: 233-246.","journal-title":"Apoptosis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1038\/s41416-021-01336-7","article-title":"RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway","volume":"124","author":"Shriwas","year":"2021","unstructured":"Shriwas O, Arya R, Mohanty S, Mohapatra P, Kumar S, Rath R, Kaushik SR, Pahwa F, Murmu KC, Majumdar SKD, Muduly DK, Dixit A, Prasad P, Nanda RK and Dash R. RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway. Br J Cancer 2021; 124: 2004-2016.","journal-title":"Br J Cancer"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.7150\/jca.13754","article-title":"Ellagic acid and resveratrol prevent the development of cisplatin resistance in the epithelial ovarian cancer cell line A2780","volume":"7","author":"Engelke","year":"2016","unstructured":"Engelke LH, Hamacher A, Proksch P and Kassack MU. Ellagic acid and resveratrol prevent the development of cisplatin resistance in the epithelial ovarian cancer cell line A2780. J Cancer 2016; 7: 353-63.","journal-title":"J Cancer"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Mohapatra P, Shriwas O, Mohanty S, Ghosh A, Smita S, Kaushik SR, Arya R, Rath R, Das Majumdar SK, Muduly DK, Raghav SK, Nanda RK and Dash R. CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1\/AKT\/GSK3&#x3B2; axis. JCI Insight 2021; 6: e143643.","DOI":"10.1172\/jci.insight.143643"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/carcin\/19.2.373","article-title":"Canthaxanthin induces apoptosis in human cancer cell lines","volume":"19","author":"Palozza","year":"1998","unstructured":"Palozza P, Maggiano N, Calviello G, Lanza P, Piccioni E, Ranelletti FO and Bartoli GM. Canthaxanthin induces apoptosis in human cancer cell lines. Carcinogenesis 1998; 19: 373-376.","journal-title":"Carcinogenesis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1021\/np900622m","article-title":"Dragonamide E, a modified linear lipopeptide from Lyngbya majuscula with antileishmanial activity","volume":"73","author":"MJ","year":"2010","unstructured":"Balunas MJ, Linington RG, Tidgewell K, Fenner AM, Ure&#xF1;a LD, Togna GD, Kyle DE and Gerwick WH. Dragonamide E, a modified linear lipopeptide from Lyngbya majuscula with antileishmanial activity. J Nat Prod 2010; 73: 60-66.","journal-title":"J Nat Prod"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3390\/antiox9060528","article-title":"Neurosporaxanthin overproduction by fusarium fujikuroi and evaluation of its antioxidant properties","volume":"9","author":"Parra-Rivero O","year":"2020","unstructured":"Parra-Rivero O, Barros MP, Prado MDM, Gil JV, Hornero-M&#xE9;ndez D, Zacar&#xED;as L, Rodrigo MJ, Lim&#xF3;n MC and Avalos J. Neurosporaxanthin overproduction by fusarium fujikuroi and evaluation of its antioxidant properties. Antioxidants (Basel) 2020; 9: 528.","journal-title":"Antioxidants (Basel)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"18095","DOI":"10.18632\/oncotarget.7741","article-title":"Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma","volume":"7","author":"Grammatikos","year":"2016","unstructured":"Grammatikos G, Schoell N, Ferreir&#xF3;s N, Bon D, Herrmann E, Farnik H, K&#xF6;berle V, Piiper A, Zeuzem S, Kronenberger B, Waidmann O and Pfeilschifter J. Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma. Oncotarget 2016; 7: 18095-18105.","journal-title":"Oncotarget"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"H&#xE4;gerstr&#xF6;m E, Lindberg L, Bentzen J, Br&#xF8;db&#xE6;k K, Zerahn B and Kristensen B. The nephroprotective effect of mannitol in head and neck cancer patients receiving cisplatin therapy. Clin Med Insights Oncol 2019; 13: 1179554918821320.","DOI":"10.1177\/1179554918821320"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"105366","DOI":"10.1016\/j.pestbp.2023.105366","article-title":"Tetraconazole interrupts mitochondrial function and intracellular calcium levels leading to apoptosis of bovine mammary epithelial cells","volume":"191","author":"Jeong","year":"2023","unstructured":"Jeong SA, Song J, Ham J, An G, Song G and Lim W. Tetraconazole interrupts mitochondrial function and intracellular calcium levels leading to apoptosis of bovine mammary epithelial cells. Pestic Biochem Physiol 2023; 191: 105366.","journal-title":"Pestic Biochem Physiol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/ijms20030656","article-title":"Molecular mechanisms of action of tocotrienols in cancer: recent trends and advancements","volume":"20","author":"Aggarwal","year":"2019","unstructured":"Aggarwal V, Kashyap D, Sak K, Tuli HS, Jain A, Chaudhary A, Garg VK, Sethi G and Yerer MB. Molecular mechanisms of action of tocotrienols in cancer: recent trends and advancements. Int J Mol Sci 2019; 20: 656.","journal-title":"Int J Mol Sci"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Park JK, Yoo MJ, Jang H, Park SY, Choi J and Seol JW. Methyl gallate suppresses tumor development by increasing activation of Caspase3 and disrupting tumor angiogenesis in melanoma. Evid Based Complement Alternat Med 2022: 6295910.","DOI":"10.1155\/2022\/6295910"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/cas.12562","article-title":"Phloroglucinol suppresses metastatic ability of breast cancer cells by inhibition of epithelial-mesenchymal cell transition","volume":"106","author":"Kim","year":"2015","unstructured":"Kim RK, Suh Y, Yoo KC, Cui YH, Hwang E, Kim HJ, Kang JS, Kim MJ, Lee YY and Lee SJ. Phloroglucinol suppresses metastatic ability of breast cancer cells by inhibition of epithelial-mesenchymal cell transition. Cancer Sci 2015; 106: 94-101.","journal-title":"Cancer Sci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12935-021-02118-0","article-title":"-Paradol suppresses proliferation and metastases of pancreatic cancer by decreasing EGFR and inactivating PI3K\/AKT signaling","volume":"21","author":"Jiang","year":"2021","unstructured":"Jiang X, Wang J, Chen P, He Z, Xu J, Chen Y, Liu X and Jiang J. -Paradol suppresses proliferation and metastases of pancreatic cancer by decreasing EGFR and inactivating PI3K\/AKT signaling. Cancer Cell Int 2021; 21: 420.","journal-title":"Cancer Cell Int"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.26650\/eurjbiol.2020.0015","article-title":"Profile of apoptotic proteins after curcumin treatment by antibody array in H69AR lung cancer cells","volume":"79","author":"Ilhan","year":"2020","unstructured":"Ilhan S. Profile of apoptotic proteins after curcumin treatment by antibody array in H69AR lung cancer cells. Eur J Biol 2020; 79: 157-162.","journal-title":"Eur J Biol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/dna.2011.1300","article-title":"Curcumin induces small cell lung cancer NCI-H446 cell apoptosis via the reactive oxygen species-mediated mitochondrial pathway and not the cell death receptor pathway","volume":"31","author":"Yang","year":"2012","unstructured":"Yang CL, Ma YG, Xue YX, Liu YY, Xie H and Qiu GR. Curcumin induces small cell lung cancer NCI-H446 cell apoptosis via the reactive oxygen species-mediated mitochondrial pathway and not the cell death receptor pathway. DNA Cell Biol 2012; 31: 139-150.","journal-title":"DNA Cell Biol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/1440-1681.12581","article-title":"Molecular mechanisms for tumour resistance to chemotherapy","volume":"43","author":"Pan","year":"2016","unstructured":"Pan ST, Li ZL, He ZX, Qiu JX and Zhou SF. Molecular mechanisms for tumour resistance to chemotherapy. Clin Exp Pharmacol Physiol 2016; 43: 723-737.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"111545","DOI":"10.1016\/j.biopha.2021.111545","article-title":"Tacrolimus inhibits oral carcinogenesis through cell cycle control","volume":"139","author":"Li","year":"2021","unstructured":"Li Y, Wang Y, Li J, Ling Z, Chen W, Zhang L, Hu Q, Wu T, Cheng B, Wang Y and Xia J. Tacrolimus inhibits oral carcinogenesis through cell cycle control. Biomed Pharmacother 2021; 139: 111545.","journal-title":"Biomed Pharmacother"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"19269","DOI":"10.1074\/jbc.272.31.19269","article-title":"Differential response in Syrian hamster embryo tumor suppressor phenotypes","volume":"272","author":"Glasgow","year":"1997","unstructured":"Glasgow WC, Hui R, Everhart AL, Jayawickreme SP, Angerman-Stewart J, Han BB and Eling TE. The linoleic acid metabolite, (13S)-hydroperoxyoctadecadienoic acid, augments the epidermal growth factor receptor signaling pathway by attenuation of receptor dephosphorylation. Differential response in Syrian hamster embryo tumor suppressor phenotypes. J Biol Chem 1997; 272: 19269-19276.","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.bbagrm.2015.06.004","article-title":"5-Lipoxygenase is a direct p53 target gene in humans","volume":"1849","author":"Gilbert","year":"2015","unstructured":"Gilbert B, Ahmad K, Roos J, Lehmann C, Chiba T, Ulrich-R&#xFC;ckert S, Smeenk L, van Heeringen S, Maier TJ, Groner B and Steinhilber D. 5-Lipoxygenase is a direct p53 target gene in humans. Biochim Biophys Acta 2015; 1849: 1003-1016.","journal-title":"Biochim Biophys Acta"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2174\/1568009614666140725090000","article-title":"Arsenic trioxide exerts anti-lung cancer activity by inhibiting angiogenesis","volume":"14","author":"Yang","year":"2014","unstructured":"Yang MH, Zang YS, Huang H, Chen K, Li B, Sun Y and Zhao XW. Arsenic trioxide exerts anti-lung cancer activity by inhibiting angiogenesis. Curr Cancer Drug Targets 2014; 14: 557-566.","journal-title":"Curr Cancer Drug Targets"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1016\/j.yexcr.2010.08.007","article-title":"Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression","volume":"316","author":"GT","year":"2010","unstructured":"McDonald GT, Sullivan R, Par&#xE9; GC and Graham CH. Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression. Exp Cell Res 2010; 316: 3197-3206.","journal-title":"Exp Cell Res"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/cancers8070060","article-title":"Wnt signaling in cancer stem cell biology","volume":"8","author":"de Sousa E Melo","year":"2016","unstructured":"de Sousa E Melo F and Vermeulen L. Wnt signaling in cancer stem cell biology. Cancers (Basel) 2016; 8: 60.","journal-title":"Cancers (Basel)"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.molcel.2014.05.015","article-title":"Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance","volume":"54","author":"Easwaran","year":"2014","unstructured":"Easwaran H, Tsai HC and Baylin SB. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell 2014; 54: 716-727.","journal-title":"Mol Cell"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/&#x3B2;-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","unstructured":"Nusse R and Clevers H. Wnt\/&#x3B2;-catenin signaling, disease, and emerging therapeutic modalities. Cell 2017; 169: 985-999.","journal-title":"Cell"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"41540","DOI":"10.18632\/oncotarget.9236","article-title":"EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt\/&#x3B2;-catenin signaling","volume":"7","author":"Chen","year":"2016","unstructured":"Chen JF, Luo X, Xiang LS, Li HT, Zha L, Li N, He JM, Xie GF, Xie X and Liang HJ. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt\/&#x3B2;-catenin signaling. Oncotarget 2016; 7: 41540-41558.","journal-title":"Oncotarget"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Ahn EH, Yang H, Hsieh CY, Sun W, Chang CC and Schroeder JJ. Evaluation of chemotherapeutic and cancer-protective properties of sphingosine and C2-ceramide in a human breast stem cell derived carcinogenesis model. Int J Oncol 2019; 54: 655-664.","DOI":"10.3892\/ijo.2018.4641"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/bjc.2013.579","article-title":"&#x3B3;-Glutamyl hydrolase modulation and folate infl uence chemosensitivity of cancer cells to 5-fl uorouracil and methotrexate","volume":"109","author":"Kim","year":"2013","unstructured":"Kim SE, Cole PD, Cho RC, Ly A, Ishiguro L, Sohn KJ, Croxford R, Kamen BA and Kim YI. &#x3B3;-Glutamyl hydrolase modulation and folate infl uence chemosensitivity of cancer cells to 5-fl uorouracil and methotrexate. Br J Cancer 2013; 109: 2175-2188.","journal-title":"Br J Cancer"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10495-005-2943-3","article-title":"Decreased apoptosis in polyamine depleted IEC-6 cells depends on Akt-mediated NF-&#x3BA;B activation but not GSK3&#x3B2; activity","volume":"10","author":"Bhattacharya","year":"2005","unstructured":"Bhattacharya S, Ray RM and Johnson LR. Decreased apoptosis in polyamine depleted IEC-6 cells depends on Akt-mediated NF-&#x3BA;B activation but not GSK3&#x3B2; activity. Apoptosis 2005; 10: 759-776.","journal-title":"Apoptosis"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1423-0127-20-43","article-title":"Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance","volume":"20","author":"Chang","year":"2013","unstructured":"Chang KY, Tsai SY, Chen SH, Tsou HH, Yen CJ, Liu KJ, Fang HL, Wu HC, Chuang BF, Chou SW, Tang CK, Liu SY, Lu PJ, Yen CY and Chang JY. Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance. J Biomed Sci 2013; 20: 43.","journal-title":"J Biomed Sci"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc1819","article-title":"Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis","volume":"6","author":"Cully","year":"2006","unstructured":"Cully M, You H, Levine AJ and Mak TW. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 2006; 6: 184-192.","journal-title":"Nat Rev Cancer"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"22192","DOI":"10.1038\/srep22192","article-title":"Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3&#x3B2; in a hamster model of oral oncogenesis","volume":"6","author":"Sophia","year":"2016","unstructured":"Sophia J, Kiran Kishore T K, Kowshik J, Mishra R and Nagini S. Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3&#x3B2; in a hamster model of oral oncogenesis. Sci Rep 2016; 6: 22192.","journal-title":"Sci Rep"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1091\/mbc.e11-06-0483","article-title":"GSK3&#x3B2; inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb","volume":"22","author":"Zhou","year":"2011","unstructured":"Zhou F, Zhang L, van Laar T, van Dam H and Ten Dijke P. GSK3&#x3B2; inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb. Mol Biol Cell 2011; 22: 3533-3540.","journal-title":"Mol Biol Cell"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/&#x3B2;-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"BT","year":"2009","unstructured":"MacDonald BT, Tamai K and He X. Wnt\/&#x3B2;-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009; 17: 9-26.","journal-title":"Dev Cell"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jhep.2015.11.005","article-title":"Enhanced expression of c-myc in hepatocytes promotes initiation and progression of alcoholic liver disease","volume":"64","author":"Nevzorova","year":"2016","unstructured":"Nevzorova YA, Cubero FJ, Hu W, Hao F, Haas U, Ramadori P, Gassler N, Hoss M, Strnad P, Zimmermann HW, Tacke F, Trautwein C and Liedtke C. Enhanced expression of c-myc in hepatocytes promotes initiation and progression of alcoholic liver disease. J Hepatol 2016; 64: 628-640.","journal-title":"J Hepatol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0955-0674(03)00008-5","article-title":"Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells","volume":"15","author":"Stacey","year":"2003","unstructured":"Stacey DW. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol 2003; 15: 158-163.","journal-title":"Curr Opin Cell Biol"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/3\/ajcr0152359.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:52:15Z","timestamp":1766022735000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/3\/ajcr0152359.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/jtnq4812","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}